Galderma Group employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Recap of Galderma Group's management performance can provide insight into the venture performance.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galderma Group N. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Galderma Group Management Team Effectiveness
The company has return on total asset (ROA) of 0.0367 % which means that it generated a profit of $0.0367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0492 %, meaning that it generated $0.0492 on every $100 dollars invested by stockholders. Galderma Group's management efficiency ratios could be used to measure how well Galderma Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Galderma Group's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.02 in 2026, whereas Return On Capital Employed is likely to drop 0.04 in 2026. At this time, Galderma Group's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 82.8 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 11 B in 2026.
Net Income Applicable To Common Shares is likely to climb to about 278.9 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 261.3 M in 2026. Galderma Group N has a total of 234.82 Million outstanding shares. Galderma Group secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Galderma Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Galderma Group, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Galderma Group N is currently under evaluation in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 83,916. Galderma Group adds roughly 0.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.
The output start index for this execution was zero with a total number of output elements of sixty-one. Galderma Group N Price Series Summation is a cross summation of Galderma Group price series and its benchmark/peer.
Galderma Group Notable Stakeholders
A Galderma Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Galderma Group often face trade-offs trying to please all of them. Galderma Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Galderma Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
The success or failure of an entity such as Galderma Group N often depends on how effective the management is. Galderma Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Galderma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Galderma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Galderma Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Galderma Group N. Check Galderma Group's Beneish M Score to see the likelihood of Galderma Group's management manipulating its earnings.
Galderma Group Workforce Analysis
Traditionally, organizations such as Galderma Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Galderma Group within its industry.
Galderma Group Manpower Efficiency
Return on Galderma Group Manpower
Revenue Per Employee
740M
Revenue Per Executive
740M
Net Income Per Employee
38.5M
Net Income Per Executive
38.5M
Additional Tools for Galderma Stock Analysis
When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.